Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To evaluate dosage and administration method, efficacy and safety of Puregon and the
relationship between background factors of patients and dose and administration method.
Post-marketing surveys are not considered applicable clinical trials and thus the results of
this survey will not be posted at its conclusion. The results will be submitted to public
health officials as required by applicable national and international laws.